Quinacrine administration to a patient with Creutzfeldt-Jakob disease who received a cadaveric dura mater graft-An EEG evaluation

Clinical Neurology

Volumn 43, Issue 7, 2003, Pages 403-408

  Kobayashi, Yuka ^a   Hirata, Koichi ^a   Tanaka, Hideaki ^a   Yamada, Tatsuo ^a  

^a NONE

Author keywords

Cadaveric dura mater graft; Creutzfeldt Jakob disease; EEG; Quinacrine

Indexed keywords

ANTIMALARIAL AGENT; MEPACRINE; PRION PROTEIN;

ADULT; ANXIETY DISORDER; ARTICLE; ASTROCYTOMA; ATAXIA; BRAIN GRAFT; CADAVER; CASE REPORT; CLINICAL TRIAL; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DRUG WITHDRAWAL; DURA MATER; ELECTROENCEPHALOGRAM; EVALUATION; EYE MOVEMENT; FEMALE; HALLUCINATION; HUMAN; LIMB MOVEMENT; LIVER DYSFUNCTION; MUSCLE RIGIDITY; MYOCLONUS; NEUROBLASTOMA CELL; SYMPTOMATOLOGY; TREATMENT OUTCOME; VOLUNTARY MOVEMENT;

ADULT; CADAVER; CREUTZFELDT-JAKOB SYNDROME; DURA MATER; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; ORGAN TRANSPLANTATION; QUINACRINE;

EID: 0142023970     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Japanese characters. http://www.mhlw.go.jp/shingi/2003/02/s0212-3.html
2. Doh-ura K, Iwaki T, Caughey B: Lysosomotropic agents and cysterine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 2000; 74: 4894-4897
3. Korth C, May BC, Cohen FE, et al: Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci 2001; 98: 9836-9841
4. Japanese characters. http://www.nanbyou.or. jp/sikkan/105.htm
5. Umezaki H, Goto K, Suetsugu M, et al: Sutudies on Pathophysiology of periodic synchronous discharge in Creutzfeldt-Jakob disease. Electroenceph Clin Neurophysiol 1977; 43: 486 (abstr)
6. Lee RG, Blair RDG: Evolution of EEG and visual evoked response changes in Jakob-Creutzfeldt desease. Electroenceph Clin Neurophysiol, 1973; 35: 133-142
7. Elliot F, Gardner-Thorpe C, Barwick DD: Jakob-Creutzfeldt disease. Modification of clinical and methyphenidate and diazepam, J Neurol Neurosurg Psychiat 1974; 37: 879-887
8. Rossini PM, Caltagrine C, David P.: Jakob-Creutzfeldt disease: Analysis EEG and Evoked Potentials under Basal Conditions and Neuroactive Drugs. Eur Neurol 1979; 18: 269-279
9. Hamoen AM: Possible association between triphasic EEG waves and disorder of doppaminergic system. Brit Med J. 1973; 3: 272-273
10. Collins SJ, Lewis V, Brazier M, et al: Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol, 2002; 52: 503-506
11. Lindenmayer JP, Vargas P: Toxic psychosis following use of quinacrine. J Clin Psychiat, 1981; 42: 162-164
12. Weisholtz SJ, McBride PA, Murray HW, et al: Quinacrine-induced psychiatric disturbances. Southern Med J, 1982; 75: 359-360
13. Engel GL, Romano J, Ferris EB: Effect of quinacrine (Atabrine) on the central nervous system. Arch Neurol Psychiat, 1947; 58: 337-350